Back to User profile » Dr Horng-Heng Juang
Papers published by Dr Horng-Heng Juang:
Comparison of Outcome and Quality of Life Between Thulium Laser (VelaTM XL) Enucleation of Prostate and Bipolar Transurethral Enucleation of the Prostate (B-TUEP)
Chen YT, Hou CP, Juang HH, Lin YH, Yang PS, Chang PL, Chen CL, Weng SC, Tsui KH
Therapeutics and Clinical Risk Management 2022, 18:145-154
Published Date: 24 February 2022
Interferon α-inducible protein 27 is an oncogene and highly expressed in cholangiocarcinoma patients with poor survival
Chiang K, Huang S, Wu RC, Huang SC, Yeh T, Chen M, Hsu JT, Chen L, Kuo SF, Chueh H, Juang H, Hung S, Yeh C, Pang JS
Cancer Management and Research 2019, 11:1893-1905
Published Date: 28 February 2019
Is diabetes mellitus associated with clinical outcomes in aging males treated with transurethral resection of prostate for bladder outlet obstruction: implications from Taiwan Nationwide Population-Based Cohort Study
Lin YH, Hou CP, Chen TH, Juang HH, Chang PL, Yang PS, Lin YS, Chen CL, Tsui KH
Clinical Interventions in Aging 2017, 12:535-541
Published Date: 16 March 2017
MART-10, a newly synthesized vitamin D analog, represses metastatic potential of head and neck squamous carcinoma cells
Yang SW, Tsai CY, Pan YC, Yeh CN, Pang JHS, Takano M, Kittaka A, Juang HH, Chen TC, Chiang KC
Drug Design, Development and Therapy 2016, 10:1995-2002
Published Date: 17 June 2016
PTEN insufficiency modulates ER+ breast cancer cell cycle progression and increases cell growth in vitro and in vivo
Chiang KC, Chen HY, Hsu SY, Pang JHS, Wang SY, Hsu JT, Yeh TS, Chen LW, Kuo SF, Sun CC, Lee JM, Yeh CN, Juang HH
Drug Design, Development and Therapy 2015, 9:4631-4638
Published Date: 13 August 2015
Neoadjuvant hormone therapy following treatment with robotic-assisted radical prostatectomy achieved favorable in high-risk prostate cancer
Hou CP, Lee WC, Lin YH, Chen SM, Chen CL, Chang PL, Juang HH, Tsui KH
OncoTargets and Therapy 2015, 8:15-19
Published Date: 17 December 2014
Risk factors associated with ineligibility of adjuvant cisplatin-based chemotherapy after nephroureterectomy
Shao IH, Lin YH, Hou CP, Juang HH, Chen CL, Chang PL, Tsui KH
Drug Design, Development and Therapy 2014, 8:1985-1991
Published Date: 21 October 2014
The expression sequence tag is an effective method for screening DNA segments that predict urinary bladder transitional cell carcinoma prognosis
Yang PS, Hsu YC, Lin YH, Hou CP, Chen CL, Chang PL, Juang HH, Tsui KH
OncoTargets and Therapy 2014, 7:1777-1781
Published Date: 30 September 2014
Prostatic urethral angle might be a predictor of treatment efficacy of α-blockers in men with lower urinary tract symptoms
Hou CP, Chen CL, Lin YH, Tsai YL, Chang PL, Juang HH, Tsui KH
Drug Design, Development and Therapy 2014, 8:937-943
Published Date: 15 July 2014
Prostatectomy using different lasers for the treatment of benign prostate hyperplasia in aging males
Lee WC, Lin YH, Hou CP, Chang PL, Chen CL, Juang HH, Tsui KH
Clinical Interventions in Aging 2013, 8:1483-1488
Published Date: 4 November 2013